$3.25
0.289.43%
At close: -
$3.25
00.00%
After Hours: Nov 22, 4:00 PM EDT
Comments
Loading...
Fulcrum Therapeutics (FULC) Forecast
NewsEarningsFulcrum Therapeutics (FULC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestFulcrum Therapeutics (NASDAQ:FULC) Stock Quotes, Forecast and News Summary
Fulcrum Therapeutics Stock (NASDAQ: FULC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Fulcrum Therapeutics (FULC) stock?
You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.
Who are Fulcrum Therapeutics (FULC) competitors?
Other companies in Fulcrum Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Aquestive Therapeutics (NASDAQ:AQST), Telomir Pharmaceuticals (NASDAQ:TELO), SIGA Technologies (NASDAQ:SIGA) and Trevi Therapeutics (NASDAQ:TRVI).
What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?
Fulcrum Therapeutics has a consensus price target of $7.50.
What is the current price for Fulcrum Therapeutics (FULC)?
The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $3.25 last updated November 22, 2024 at 4:00 PM EST.
Does Fulcrum Therapeutics (FULC) pay a dividend?
There are no upcoming dividends for Fulcrum Therapeutics.
When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?
Fulcrum Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Fulcrum Therapeutics (FULC) going to split?
There is no upcoming split for Fulcrum Therapeutics.
What sector and industry does Fulcrum Therapeutics (FULC) operate in?
Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.